depression
BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 ...
BPL‐003 holds Breakthrough Therapy Designation and is supported by positive Phase 2b results in treatment-resistant depressionCash runway reaffirmed through the planned early-2029 topline readouts from both parallel Phase 3 pivotal studiesCommercial readiness advancing with scalable treatment model aligned to existing...
Top FDA drug official is trying to hire a friend who’s seeking a warning about unproven side effects of antidepressants | CNN
The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new warnings to antidepressants about unproven pregnancy risks, The Associated Press has learned.
Scientists discover protein that triggers diabetic blindness
A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the earliest damage in diabetic retinopathy by constricting tiny retinal blood vessels and reducing oxygen supply. In mice, shutting down this protein stopped the damage before it could take hold. The finding could pave the way for treatments that protect vision before symptoms ever begin.
Depression is more than sadness. It can be debilitating.
People living with depression cannot just get over it. They need support, healing, and to discover the epicenter of their pain.
New FDA warning on antidepressants during pregnancy could harm women, doctors say
Top FDA regulator Dr. Tracy Beth Hoeg is accused of bypassing standard recusal rules to advance a friend's push for new antidepressant warning labels.
Top FDA drug official is trying to hire a friend who's seeking a bold new warning on antidepressants
WASHINGTON — The Food and Drug Administration's top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new warnings to antidepressants about unproven pregnancy risks, The Associated Press has...
Top FDA drug official is trying to hire a friend who’s seeking a bold new warning on antidepressants
The antidepressant review is the latest in a series of controversial topics taken up by Hoeg.
BrainsWay (BWAY) Announces Breakthrough in Depression Treatment
Israeli pharma shakes industry with breakthrough drug
FDA Approves Fast-Acting Postpartum Depression Pill
New antidepressants: tackling treatment resistant depression